Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 274

1.

Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities.

Campbell LM, Fennema-Notestine C, Saloner R, Hussain M, Chen A, Franklin D, Umlauf A, Ellis RJ, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, McCutchan JA, Letendre S, Grant I, Heaton RK; CHARTER Group.

J Int Neuropsychol Soc. 2019 Oct 2:1-16. doi: 10.1017/S1355617719000985. [Epub ahead of print]

PMID:
31576785
2.

Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.

Livelli A, Vaida F, Ellis RJ, Ma Q, Ferrara M, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Sacktor N, Simpson DM, Grant I, Letendre SL; CHARTER Group.

Lancet HIV. 2019 Jul;6(7):e456-e462. doi: 10.1016/S2352-3018(19)30143-2. Epub 2019 Jun 14.

3.

Knowledge, Attitudes, and Practice Regarding Research Ethics Committees Among Health Care Faculty at Two Public Universities in Jordan.

Ayoub NM, Qandil AM, McCutchan JA.

J Empir Res Hum Res Ethics. 2019 Oct;14(4):372-382. doi: 10.1177/1556264619851351. Epub 2019 Jun 6.

PMID:
31169072
4.

COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk of Neurocognitive Impairment in Men Living With HIV.

Saloner R, Marquine MJ, Sundermann EE, Hong S, McCutchan JA, Ellis RJ, Heaton RK, Grant I, Cherner M.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):e148-e157. doi: 10.1097/QAI.0000000000002083.

PMID:
31107306
5.

Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates.

Saloner R, Campbell LM, Serrano V, Montoya JL, Pasipanodya E, Paolillo EW, Franklin D, Ellis RJ, Letendre SL, Collier AC, Clifford DB, Gelman BB, Marra CM, McCutchan JA, Morgello S, Sacktor N, Jeste DV, Grant I, Heaton RK, Moore DJ; CHARTER and HNRP Groups.

J Int Neuropsychol Soc. 2019 May;25(5):507-519. doi: 10.1017/S1355617719000018. Epub 2019 Mar 20.

6.

Effects of comorbidity burden and age on brain integrity in HIV.

Saloner R, Heaton RK, Campbell LM, Chen A, Franklin D Jr, Ellis RJ, Collier AC, Marra C, Clifford DB, Gelman B, Sacktor N, Morgello S, McCutchan JA, Letendre S, Grant I, Fennema-Notestine C; CHARTER Study Group.

AIDS. 2019 Jun 1;33(7):1175-1185. doi: 10.1097/QAD.0000000000002192.

PMID:
30870195
7.

Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects.

Pérez-Valero I, Ellis R, Heaton R, Deutsch R, Franklin D, Clifford DB, Collier A, Gelman B, Marra C, McCutchan JA, Navis A, Sacktor N, Simpson D, Grant I, Letendre S.

AIDS. 2019 Mar 1;33(3):475-481. doi: 10.1097/QAD.0000000000002074.

PMID:
30702516
8.

Cognitive Impairment in Zambians With HIV Infection and Pulmonary Tuberculosis.

Hestad KA, Chinyama J, Anitha MJ, Ngoma MS, McCutchan JA, Franklin DR Jr, Heaton RK.

J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):110-117. doi: 10.1097/QAI.0000000000001880.

PMID:
30531294
9.

Brief Report: Body Mass Index and Cognitive Function Among HIV-1-Infected Individuals in China, India, and Nigeria.

Jumare J, El-Kamary SS, Magder L, Hungerford L, Umlauf A, Franklin D, Ghate M, Abimiku A, Charurat M, Letendre S, Ellis RJ, Mehendale S, Blattner WA, Royal W 3rd, Marcotte TD, Heaton RK, Grant I, McCutchan JA.

J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):e30-e35. doi: 10.1097/QAI.0000000000001906.

PMID:
30422905
10.

White matter damage, neuroinflammation, and neuronal integrity in HAND.

Alakkas A, Ellis RJ, Watson CW, Umlauf A, Heaton RK, Letendre S, Collier A, Marra C, Clifford DB, Gelman B, Sacktor N, Morgello S, Simpson D, McCutchan JA, Kallianpur A, Gianella S, Marcotte T, Grant I, Fennema-Notestine C; CHARTER Group.

J Neurovirol. 2019 Feb;25(1):32-41. doi: 10.1007/s13365-018-0682-9. Epub 2018 Oct 5.

11.

Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.

Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS, Heaton R, Samuels DC, Franklin DR Jr, Rosario-Cookson D, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, McCutchan JA, Morgello S, Grant I, Simpson D, Connor JR, Hulgan T; CHARTER Study Group.

Mol Neurobiol. 2019 May;56(5):3808-3818. doi: 10.1007/s12035-018-1329-9. Epub 2018 Sep 12.

PMID:
30209774
12.

Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States.

Marquine MJ, Heaton A, Johnson N, Rivera-Mindt M, Cherner M, Bloss C, Hulgan T, Umlauf A, Moore DJ, Fazeli P, Morgello S, Franklin D, Letendre S, Ellis R, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Simpson D, McCutchan JA, Grant I, Heaton RK.

J Int Neuropsychol Soc. 2018 Feb;24(2):163-175. doi: 10.1017/S1355617717000832. Epub 2017 Sep 6.

13.

Prevalence and Risk Factors for Human Immunodeficiency Virus (HIV) and Syphilis Infections Among Military Personnel in Sierra Leone.

Djibo DA, Sahr F, McCutchan JA, Jain S, Araneta MRG, Brodine SK, Shaffer RA.

Curr HIV Res. 2017;15(2):128-136. doi: 10.2174/1570162X15666170517101349.

PMID:
28521722
14.

Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.

Jia P, Zhao Z, Hulgan T, Bush WS, Samuels DC, Bloss CS, Heaton RK, Ellis RJ, Schork N, Marra CM, Collier AC, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, McCutchan JA, Barnholtz-Sloan JS, Franklin DR, Rosario D, Letendre SL, Grant I, Kallianpur AR; CHARTER Study Group.

Am J Med Genet B Neuropsychiatr Genet. 2017 Jun;174(4):413-426. doi: 10.1002/ajmg.b.32530. Epub 2017 Apr 26.

15.

Liver histology and diffusion-weighted MRI in children with nonalcoholic fatty liver disease: A MAGNET study.

Manning P, Murphy P, Wang K, Hooker J, Wolfson T, Middleton MS, Newton KP, Behling C, Awai HI, Durelle J, Paiz MN, Angeles JE, De La Pena D, McCutchan JA, Schwimmer JB, Sirlin CB.

J Magn Reson Imaging. 2017 Oct;46(4):1149-1158. doi: 10.1002/jmri.25663. Epub 2017 Feb 22.

16.

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.

Anderson AM, Muñoz-Moreno JA, McClernon DR, Ellis RJ, Cookson D, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Sacktor N, Simpson DM, Franklin DR, Heaton RK, Grant I, Letendre SL; CHARTER Group.

J Infect Dis. 2017 Jan 1;215(1):105-113. doi: 10.1093/infdis/jiw505. Epub 2016 Oct 26.

17.

Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND.

Obermeit LC, Beltran J, Casaletto KB, Franklin DR, Letendre S, Ellis R, Fennema-Notestine C, Vaida F, Collier AC, Marra CM, Clifford D, Gelman B, Sacktor N, Morgello S, Simpson D, McCutchan JA, Grant I, Heaton RK; CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2017 Feb;23(1):67-78. doi: 10.1007/s13365-016-0474-z. Epub 2016 Aug 24.

18.

Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals.

Cooley SA, Paul RH, Fennema-Notestine C, Morgan EE, Vaida F, Deng Q, Chen JA, Letendre S, Ellis R, Clifford DB, Marra CM, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Morgello S, Grant I, Ances BM; CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2016 Oct;22(5):607-614. Epub 2016 Mar 28.

19.

Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.

Kallianpur AR, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre SL, Ellis RJ, Heaton RK, Franklin DR, Barnholtz-Sloan J, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I; CHARTER Study Group.

J Infect Dis. 2016 Apr 1;213(7):1065-73. doi: 10.1093/infdis/jiv754. Epub 2015 Dec 21.

20.

Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia.

Fazeli PL, Moore DJ, Franklin DR, Umlauf A, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor NC, Morgello S, Simpson DM, McCutchan JA, Grant I, Letendre SL.

Curr HIV Res. 2016;14(4):324-30.

21.

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.

Hulgan T, Samuels DC, Bush W, Ellis RJ, Letendre SL, Heaton RK, Franklin DR, Straub P, Murdock DG, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I, Kallianpur AR; CHARTER Group.

Clin Infect Dis. 2015 Nov 1;61(9):1476-84. doi: 10.1093/cid/civ527. Epub 2015 Jun 30.

22.

CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease.

Anderson AM, Fennema-Notestine C, Umlauf A, Taylor MJ, Clifford DB, Marra CM, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Morgello S, Grant I, Letendre SL; CHARTER Group.

J Neurovirol. 2015 Oct;21(5):559-67. doi: 10.1007/s13365-015-0359-6. Epub 2015 Jun 12.

23.

Reply to Haddow et al.

Heaton RK, Franklin DR Jr, Deutsch R, Letendre SL, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Grant I; CHARTER Group.

Clin Infect Dis. 2015 May 1;60(9):1442-3. doi: 10.1093/cid/civ045. Epub 2015 Feb 2. No abstract available.

24.

Cluster Analysis of the Klein Sexual Orientation Grid in Clinical and Nonclinical Samples: When Bisexuality Is Not Bisexuality.

Weinrich JD, Klein F, McCutchan JA, Grant I; the HNRC Group.

J Bisex. 2014;14(3-4):349-372.

25.

Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation.

Sattler FR, He J, Letendre S, Wilson C, Sanders C, Heaton R, Ellis R, Franklin D, Aldrovandi G, Marra CM, Clifford D, Morgello S, Grant I, McCutchan JA; CHARTER Group.

J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):281-8. doi: 10.1097/QAI.0000000000000458.

26.

Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.

Heaton RK, Franklin DR Jr, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst AC, Fennema-Notestine C, Smith DM, Grant I; CHARTER Group.

Clin Infect Dis. 2015 Feb 1;60(3):473-80. doi: 10.1093/cid/ciu862. Epub 2014 Oct 31.

27.

Brain morphometric correlates of metabolic variables in HIV: the CHARTER study.

Archibald SL, McCutchan JA, Sanders C, Wolfson T, Jernigan TL, Ellis RJ, Ances BM, Collier AC, McArthur JC, Morgello S, Simpson DM, Marra C, Gelman BB, Clifford DB, Grant I, Fennema-Notestine C; CHARTER Group.

J Neurovirol. 2014 Dec;20(6):603-11. doi: 10.1007/s13365-014-0284-0. Epub 2014 Sep 17.

28.

Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy.

Kallianpur AR, Jia P, Ellis RJ, Zhao Z, Bloss C, Wen W, Marra CM, Hulgan T, Simpson DM, Morgello S, McArthur JC, Clifford DB, Collier AC, Gelman BB, McCutchan JA, Franklin D, Samuels DC, Rosario D, Holzinger E, Murdock DG, Letendre S, Grant I; CHARTER Study Group.

PLoS One. 2014 Aug 21;9(8):e103123. doi: 10.1371/journal.pone.0103123. eCollection 2014.

29.

Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.

Grant I, Franklin DR Jr, Deutsch R, Woods SP, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Heaton RK; CHARTER Group.

Neurology. 2014 Jun 10;82(23):2055-62. doi: 10.1212/WNL.0000000000000492. Epub 2014 May 9.

30.

Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohort.

Biswas B, Spitznagel E, Collier AC, Gelman BB, McArthur JC, Morgello S, McCutchan JA, Clifford DB; the CHARTER Group.

J HIV AIDS Soc Serv. 2014 Jan 1;13(1):8-25.

31.

HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter.

Keltner JR, Fennema-Notestine C, Vaida F, Wang D, Franklin DR, Dworkin RH, Sanders C, McCutchan JA, Archibald SL, Miller DJ, Kesidis G, Cushman C, Kim SM, Abramson I, Taylor MJ, Theilmann RJ, Julaton MD, Notestine RJ, Corkran S, Cherner M, Duarte NA, Alexander T, Robinson-Papp J, Gelman BB, Simpson DM, Collier AC, Marra CM, Morgello S, Brown G, Grant I, Atkinson JH, Jernigan TL, Ellis RJ; CHARTER Group.

J Neurovirol. 2014 Jun;20(3):209-18. doi: 10.1007/s13365-014-0236-8. Epub 2014 Feb 19.

32.

Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder.

Ellis RJ, Letendre S, Vaida F, Haubrich R, Heaton RK, Sacktor N, Clifford DB, Best BM, May S, Umlauf A, Cherner M, Sanders C, Ballard C, Simpson DM, Jay C, McCutchan JA.

Clin Infect Dis. 2014 Apr;58(7):1015-22. doi: 10.1093/cid/cit921. Epub 2013 Dec 18.

33.

Neurocognitive impairment in HIV-infected individuals with previous syphilis.

Marra CM, Deutsch R, Collier AC, Morgello S, Letendre S, Clifford D, Gelman B, McArthur J, McCutchan JA, Simpson DM, Duarte NA, Heaton RK, Grant I.

Int J STD AIDS. 2013 May;24(5):351-5. doi: 10.1177/0956462412472827. Epub 2013 Jun 14.

34.

Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection.

Fennema-Notestine C, Ellis RJ, Archibald SL, Jernigan TL, Letendre SL, Notestine RJ, Taylor MJ, Theilmann RJ, Julaton MD, Croteau DJ, Wolfson T, Heaton RK, Gamst AC, Franklin DR Jr, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I; CHARTER Group.

J Neurovirol. 2013 Aug;19(4):393-401. doi: 10.1007/s13365-013-0185-7. Epub 2013 Jul 10.

35.

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.

Morgan EE, Woods SP, Letendre SL, Franklin DR, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Ellis RJ, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Grant I, Vaida F, Clifford DB; CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2013 Apr;19(2):150-6. doi: 10.1007/s13365-013-0152-3. Epub 2013 Feb 14.

36.

Etravirine in CSF is highly protein bound.

Nguyen A, Rossi S, Croteau D, Best BM, Clifford D, Collier AC, Gelman B, Marra C, McArthur J, McCutchan JA, Morgello S, Simpson D, Ellis RJ, Grant I, Capparelli E, Letendre S; CHARTER Group.

J Antimicrob Chemother. 2013 May;68(5):1161-8. doi: 10.1093/jac/dks517. Epub 2013 Jan 20.

37.

Biogeochemistry of beetle-killed forests: explaining a weak nitrate response.

Rhoades CC, McCutchan JH Jr, Cooper LA, Clow D, Detmer TM, Briggs JS, Stednick JD, Veblen TT, Ertz RM, Likens GE, Lewis WM Jr.

Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1756-60. doi: 10.1073/pnas.1221029110. Epub 2013 Jan 14.

38.

Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons.

Andrade AS, Deutsch R, A Celano S, Duarte NA, Marcotte TD, Umlauf A, Atkinson JH, McCutchan JA, Franklin D, Alexander TJ, McArthur JC, Marra C, Grant I, Collier AC.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):282-92. doi: 10.1097/QAI.0b013e31827ed678.

39.

Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration.

Croteau D, Rossi SS, Best BM, Capparelli E, Ellis RJ, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur J, McCutchan JA, Morgello S, Simpson DM, Grant I, Letendre S; CHARTER Group.

J Antimicrob Chemother. 2013 Mar;68(3):684-9. doi: 10.1093/jac/dks441. Epub 2012 Nov 9.

40.

Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort.

Sakamoto M, Marcotte TD, Umlauf A, Franklin D Jr, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, Woods SP, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson D, Grant I; CHARTER Group.

J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):36-42. doi: 10.1097/QAI.0b013e318278ffa4.

41.

Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.

Holzinger ER, Hulgan T, Ellis RJ, Samuels DC, Ritchie MD, Haas DW, Kallianpur AR, Bloss CS, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Franklin DR, Rosario D, Selph D, Letendre S, Grant I; CHARTER Group.

J Neurovirol. 2012 Dec;18(6):511-20. doi: 10.1007/s13365-012-0133-y. Epub 2012 Oct 17.

42.

Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment.

Hightower GK, Wong JK, Letendre SL, Umlauf AA, Ellis RJ, Ignacio CC, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM; CHARTER Study Group.

Virology. 2012 Nov 25;433(2):498-505. doi: 10.1016/j.virol.2012.08.028. Epub 2012 Sep 20.

43.

Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV.

Patton DE, Woods SP, Franklin D Jr, Cattie JE, Heaton RK, Collier AC, Marra C, Clifford D, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan JA, Grant I.

AIDS Behav. 2012 Nov;16(8):2286-96. doi: 10.1007/s10461-012-0237-7.

44.

Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria.

Royal W 3rd, Cherner M, Carr J, Habib AG, Akomolafe A, Abimiku A, Charurat M, Farley J, Oluyemisi A, Mamadu I, Johnson J, Ellis R, McCutchan JA, Grant I, Blattner WA.

J Neurovirol. 2012 Jun;18(3):191-9. doi: 10.1007/s13365-012-0097-y. Epub 2012 Apr 18. Erratum in: J Neurovirol. 2012 Oct;18(5):441. McCutchen, J Allen [corrected to McCutchan, J Allen].

45.

Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat.

Choi JY, Hightower GK, Wong JK, Heaton R, Woods S, Grant I, Marcotte TD, Ellis RJ, Letendre SL, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Richman DD, Smith DM; Charter Group.

J Neurovirol. 2012 Apr;18(2):81-90. doi: 10.1007/s13365-011-0059-9. Epub 2012 Apr 13.

46.

Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder.

McCutchan JA, Marquie-Beck JA, Fitzsimons CA, Letendre SL, Ellis RJ, Heaton RK, Wolfson T, Rosario D, Alexander TJ, Marra C, Ances BM, Grant I; CHARTER Group.

Neurology. 2012 Feb 14;78(7):485-92. doi: 10.1212/WNL.0b013e3182478d64.

47.

Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration.

Croteau D, Best BM, Letendre S, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Grant I; CHARTER Group.

AIDS. 2012 Apr 24;26(7):890-3. doi: 10.1097/QAD.0b013e328351f627.

48.

Therapeutic amprenavir concentrations in cerebrospinal fluid.

Croteau D, Letendre S, Best BM, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur J, McCutchan JA, Morgello S, Simpson DM, Way L, Capparelli E, Grant I; CHARTER Group.

Antimicrob Agents Chemother. 2012 Apr;56(4):1985-9. doi: 10.1128/AAC.05098-11. Epub 2012 Jan 30.

49.

Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir.

Best BM, Letendre SL, Koopmans P, Rossi SS, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Capparelli EV, Ellis RJ, Grant I; CHARTER Study Group.

J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):376-81. doi: 10.1097/QAI.0b013e318247ec54.

50.

Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons.

Moore DJ, Arce M, Moseley S, McCutchan JA, Marquie-Beck J, Franklin DR, Vaida F, Achim CL, McArthur J, Morgello S, Simpson DM, Gelman BB, Collier AC, Marra CM, Clifford DB, Heaton RK, Grant I; Charter Group and HNRC Group.

J Neuropsychiatry Clin Neurosci. 2011 Summer;23(3):316-23. doi: 10.1176/appi.neuropsych.23.3.316.

Supplemental Content

Loading ...
Support Center